Cargando…
Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma
Middle ear cholesteatoma is a destructive disease in which inflammation plays an important role in development and progression, and there are currently no biomarkers predicting prognosis or recurrence. Cylindromatosis (CYLD), a tumor suppressor deubiquitinase, serves as a negative regulator of infla...
Autores principales: | Miyake, Shunsuke, Miwa, Toru, Yoneda, Go, Kanemaru, Ayumi, Saito, Haruki, Minoda, Ryosei, Orita, Yorihisa, Saito, Hideyuki, Jono, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544047/ https://www.ncbi.nlm.nih.gov/pubmed/33031450 http://dx.doi.org/10.1371/journal.pone.0240216 |
Ejemplares similares
-
Non-microscopic Middle Ear Cholesteatoma Surgery: A Case Report of a Novel Head-Up Approach
por: Minoda, Ryosei, et al.
Publicado: (2019) -
Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Suenaga, Naoki, et al.
Publicado: (2019) -
Role of Dach1 revealed using a novel inner ear-specific Dach1-knockdown mouse model
por: Miwa, Toru, et al.
Publicado: (2019) -
Prenatal electroporation-mediated gene transfer restores Slc26a4 knock-out mouse hearing and vestibular function
por: Takeda, Hiroki, et al.
Publicado: (2019) -
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance
por: Kanemaru, Ayumi, et al.
Publicado: (2022)